More phenol spray promethazine care for children with lower respiratory tract infection in particle analysis and description of the questionable.doc

 PAGE \* MERGEFORMAT 11 More phenol spray promethazine care for children with lower respiratory tract infection in particle analysis and description of the questionable Author: Dou Tian Rong, Hu Xiaohong, Qin Lizhong [Abstract] Objective: To investigate the more phenol spray particles in pediatric care promethazine clinical application and use of instructions related to pediatric doses and related problems for discussion. Methods: The medical records were reviewed randomly selected archival investigations in combination with literature analysis. Results: 110 medical records, the two children under the age of 98 cases, accounting for 89% (98/110); for lower respiratory tract infections in children (LRI) 95 cases, accounting for 86.4% (95/110); for LRI risk children in the sputum thickens 38 cases, accounting for 40% (38/95); for the difficulties in 35 cases of expectoration, accounting for 36.8% (35/95). After use without significant improvement in respiratory status of 62 cases, accounting for 65.3% (62/95). Conclusion: The more care promethazine phenol spray particles are indications for the LRI outside to use, more inappropriate for children with LRI, and proposed amendments to the instructions on the pediatric dose of some of its contents to guide the clinical use of drugs. [Keywords:] the more phenol spray care promethazine; children; lower respiratory tract infection [Abstract] Objective: To explore pediatric dosage of Sulfogaiacol Pentoxyverine in lower respiratory tract infection.Methods: Randomly selected medical records were retrospectively surveyed.Results: Sulfogaiacol Pentoxyverine were given to 95 children with lower respiratory infection (LRI) which occupied 86.4% (95 / 110), 98 cases younger than 2 years old, 89% (98/110), 38 cases with thick sputum, 40% (38/95) and 35 with difficult expectoration, 36.8% (35/95). 62 cases had no improvement in breathing condition taking 65.3% (62/95). Coclusions: Sulfogaiacol Pentoxyverine should not be used